Overview

Alfuzosin Versus Placebo in Acute Urinary Retention

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to investigate if 14 days of treatment with Alfuzosin compared to placebo, will increase the number of patients with satisfying spontaneous voiding after acute urinary retention treated with Clean Self-Catheterization. Furthermore is investigated the safety of the medical treatment and self-catheterization.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Treatments:
Alfuzosin